Clinical Presentation and Pharmacological Therapy in Corticobasal Degeneration
Open Access
- 1 July 1998
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 55 (7) , 957-961
- https://doi.org/10.1001/archneur.55.7.957
Abstract
IN 1967 and 1968, Rebeiz et al1,2 described the clinical and pathologic findings in 3 patients who presented with slowness, awkwardness of volitional movement, and superimposed involuntary movements. All 3 were asymmetrically involved at onset with relatively preserved intellect until death. The duration of the illness until death was 6 to 8 years. Pathologic evaluation showed frontoparietal atrophy, asymmetrical in 2 cases, characterized histologically by neuronal loss, gliosis, and a distinctive neuronal change consisting of swelling of the cell body and resistance to staining methods (achromasia). They called the syndrome cortico-dentato-nigral degeneration with neuronal achromasia.Keywords
This publication has 9 references indexed in Scilit:
- III. Cortical-Basal Ganglionic DegenerationPublished by Georg Thieme Verlag KG ,2007
- Magnetic Resonance Imaging of Corticobasal DegenerationJournal of Neuroimaging, 1996
- Unique myoclonic pattern in corticobasal degenerationMovement Disorders, 1995
- Psychiatric symptoms, atypical dementia, and left visual field inattention in corticobasal ganglionic degenerationMovement Disorders, 1995
- Corticobasal degeneration: A clinical study of 36 casesBrain, 1994
- Eye movements in parkinsonian syndromesAnnals of Neurology, 1994
- The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography.Journal of Neurology, Neurosurgery & Psychiatry, 1991
- Corticonigral degeneration with neuronal achromasia and basal neurofibrillary tanglesActa Neuropathologica, 1990
- Corticodentatonigral Degeneration With Neuronal AchromasiaArchives of Neurology, 1968